Products
Solid Tumors
Pan-Cancer
Cancer Type-Specific
Minimal Residual Disease
Hematologic Malignancies
Pan-Cancer
Cancer Type-Specific
Cancer Early Detection
Hereditary Cancers
Services
Central Lab Testing
Local Testing Solutions
IVD Kit Solutions
RUO Kit Solutions
Research Services
DNA Sequencing
RNA Sequencing
Technology
Our Technology
Publications
Partnerships
About Us
What is Precision Oncology?
Our Company
Our Team
Certificates & Accreditation
News
Newsroom
Geneseeq Blogs
Join Us
Contact Us
Search
May 16, 2023
Geneseeq published new research on the clinical use of circulating-free DNA fragmentomic in monitoring minimal residual disease for patients with non-small-cell lung cancer
by Geneseeq
August 3, 2022
GENESEEQ AND COLLABORATORS SHARE NEW FINDINGS AT WORLD CONFERENCE ON LUNG CANCER 2022
by GENESEEQ
July 5, 2022
Geneseeq and collaborators publish new findings from DECIPHER series, exploring single cfDNA feature-based machine learning model for lung cancer early detection
by GENESEEQ
Privacy Preference Center
Privacy Preferences
×
